Lyric Pharmaceuticals Secures $20,400,000 Series A Financing

  • Feed Type
  • Date
    3/2/2015
  • Company Name
    Lyric Pharmaceuticals
  • Mailing Address
    601 Gateway Boulevard South San Francisco, CA 94080 USA
  • Company Description
    Lyric is a clinical stage company developing novel gastrointestinal therapeutics for unmet medical needs in the hospital setting.
  • Website
    http://www.lyricpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,400,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The current financing will enable the company to perform two clinical studies, including a clinical proof of concept study, in addition to other supportive activities.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy